Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domestic recombinant FSH versus urinary FSH in controlled ovarian stimulation
ChiCTR2200063529Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- May 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of recombinant human follicle stimulating hormone and urofollitropin in infertility (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Number of retrieved oocytes. Started May 2022; status: recruiting.
02
Drugs
recombinant human follicle stimulating hormoneurofollitropin
03
Conditions
infertility
Beyond the preview
Go deeper on ChiCTR2200063529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063529.